Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · March 03, 2014

Temporary Interruption of Rivaroxaban vs Warfarin in Patients With Nonvalvular Atrial Fibrillation

Circulation

 

Additional Info

Circulation
Outcomes of Temporary Interruption of Rivaroxaban Compared With Warfarin in Patients With Nonvalvular Atrial Fibrillation: Results From ROCKET AF
Circulation 2014 Feb 19;[EPub Ahead of Print], MW Sherwood, JD Douketis, MR Patel, JP Piccini, AS Hellkamp, Y Lokhnygina, AC Spyropoulos, GJ Hankey, DE Singer, CC Nessel, KW Mahaffey, KAA Fox, RM Califf, RC Beckerecker

Further Reading